Access cutting-edge multiple myeloma treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.
Access multiple myeloma specialists in Houston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple myeloma treatment provided free
This study will assess the safety, tolerability, pharmacokinetics (PK) and the therapeutic potential of HDP-101 in patients with plasma cell disorders including multiple myeloma.
Sponsor: Heidelberg Pharma AG
Check if you qualify for this multiple myeloma clinical trial in Houston, TX
If you're searching for multiple myeloma treatment options in Houston, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.